Lifecore Renova Dental Implant Sales Make Impression With Investors
This article was originally published in The Gray Sheet
Executive Summary
Strong sales of Lifecore Biomedical's recently unveiled Renova internal hex dental implant system are aiding double-digit revenue growth at the firm and helped drive a 43.4% August stock gain to $7.10